venerdì 21 febbraio 2014

Edoardo Cignoli : New Glaxo COPD Drug Advances

An experimental drug from GlaxoSmithKline to relieve symptoms of chronic obstructive pulmonary disease, or COPD, was recommended for marketing approval in Europe, the drug maker said Friday.



via WSJ.com: US Business http://ift.tt/MH7sO4

Nessun commento:

Posta un commento